Clinical Trials Directory

Trials / Conditions / Hepatitis D, Chronic

Hepatitis D, Chronic

14 registered clinical trials studyying Hepatitis D, Chronic — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPhase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D
NCT07309380
Shanghai HEP Pharmaceutical Co., Ltd.Phase 3
Active Not RecruitingFinite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained C
NCT06603311
Hannover Medical SchoolN/A
Active Not RecruitingSOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
NCT05461170
Vir Biotechnology, Inc.Phase 2
UnknownOnce Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infe
NCT05229991
Soroka University Medical CenterPhase 3
CompletedA Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Vi
NCT04535544
Janssen Research & Development, LLCPhase 2
RecruitingNational Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
NCT04166266
ANRS, Emerging Infectious Diseases—
CompletedA Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Inf
NCT02765802
Eiger BioPharmaceuticalsPhase 2
CompletedA Long Term Follow-up Study of Patients From the REP 301 Protocol
NCT02876419
Replicor Inc.—
UnknownPegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D
NCT03105310
Aga Khan UniversityPhase 2
TerminatedAn Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With
NCT01861444
Hoffmann-La Roche—
CompletedA Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hep
NCT01088659
Hoffmann-La RochePhase 3
CompletedEfficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection
NCT00686790
Merck Sharp & Dohme LLCPhase 3
CompletedA Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
NCT02732639
Hoffmann-La RochePhase 3
CompletedA Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)
NCT02731131
Hoffmann-La RochePhase 2